ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard In Deal To Settle Hernia Suits, Sees $184 Million 2Q Charge

By Jon Kamp Of DOW JONES NEWSWIRES Medical device maker C.R. Bard Inc. (BCR) has reached a $184 million agreement to settle most of the lawsuits involving faulty hernia repair products it started pulling from the market years ago. The company disclosed in a regulatory filing that it expects to take a charge for the settlement--$181 million after taxes--in the second quarter. Bard struck the agreement in principle with plaintiffs' law firms, and a certain number of plaintiffs need to sign off to make it official, the company said in a Securities and Exchange Commission filing late Thursday. The company faced more than 3,500 federal and state lawsuits as of April 21, according to an earlier SEC filing. The suits involve certain sizes and lots of "Composix Kugel" products Bard voluntarily recalled starting in December 2005 because a component could break, potentially leading to issues including bowel perforations. The suits generally seek damages for personal injury, Bard said. The company said the agreement in principle covers the majority of the hernia product claims. But the second-quarter charge excludes any costs associated with pending class-action suits. As of late April, Bard said none of the class actions have been certified. There were two putative class-action suits in the U.S., including one that consolidates 10 previously filed U.S. class-action suits, four in Canada, Bard said in the April SEC filing. Shares of the Murray Hill, N.J., company rose 70 cents to $109.86 Thursday and were unchanged after hours. -By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
04/24/201513:46:57Quarterly Report (10-q)
04/24/201510:52:50Barclays Boosts C.R. Bard Price Target to $185.00 (BCR)
04/24/201507:43:59C.R. Bard Upgraded at Bank of America (BCR)
04/23/201516:20:52Current Report Filing (8-k)
04/23/201516:05:00Bard Announces First Quarter Results
04/17/201506:03:35Current Report Filing (8-k)
04/15/201516:05:00Bard Declares Quarterly Dividend
04/09/201508:32:08Current Report Filing (8-k)
04/01/201515:30:00Bard to Host Earnings Conference Call on April 23, 2015
03/30/201510:19:38The Best Stocks To Buy This Week
03/26/201503:20:53Top Large Cap Stocks That Investors Can Buy Now
03/25/201509:39:29Statement of Changes in Beneficial Ownership (4)
03/13/201513:21:30Proxy Statement (definitive) (def 14a)
03/07/201500:36:53Ranking The Dividend Champions
03/06/201508:04:35J & J on the hook for $5.7M in California mesh trial
03/04/201512:00:00Bard to Present at Barclays Global Healthcare Conference
03/01/201505:02:23Some Companies Are More Wonderful Than Others
03/01/201504:33:35The Best Scoring Stocks To Buy Now
02/26/201518:22:23Statement of Changes in Beneficial Ownership (4)
02/25/201510:30:00Bard to Present at Raymond James Institutional Investors Conference

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad